|
|
|
|
| TRADING CENTER |
55.92-0.56 / -0.99%
Amgen Inc (NASDAQ GS:AMGN)
Prev. Close:
56.48
Open:
56.00
High:
56.21
Low:
55.72
Volume:
2,830,301
Volume Avg.:
7,128,100
52wk Range:
44.96 - 64.76
Market Cap (mil):
56,598.76
P/E Ratio:
10.69
Dividend Yield:
N/A
| Amgen's stock buyback plan could boost shares - DailyFinance | |
| Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP - PR Newswire | |
| Amgen draws skeptical option trade after hiking buyback program - Bloggingstocks.com | |
| Amgen sets new buyback of underperforming shares - Reuters | |
| US stocks rise in choppy trading - FT.com | |
| Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program - PR Newswire | |
| Nplate(R) Data From MDS Studies Presented at ASH - PR Newswire | |
| Better Biotech Buy: Celgene or Genzyme? - MotleyFool.com | |
| I Turned $3,000 into $210,000 - MotleyFool.com | |
| McMillan: Tech talk, trades and an agriculture ETF - Bloggingstocks.com | |
| Tired of Waiting, Teva Advances - MotleyFool.com | |
| Buy This Investment if You Want to Lose Money - MotleyFool.com | |
| Teva Carries Israel and Biotech ETFs ($) - at TheStreet.com | |
| Teva seeks FDA nod for biosimilar of Amgen drug - Reuters | |
| Amgen Highlights Data to be Presented at ASH - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | 46.09 | -0.53 / -1.14% | 17.80 |
| CELG | Celgene Corporation | 54.37 | -1.16 / -2.09% | 65.51 |
| BIIB | Biogen Idec Inc | 47.98 | -0.33 / -0.67% | 16.10 |
Short Interest Date:
Nov 13 2009
Short Interest Shares:
15,888,876
Short Interest Ratio:
1.8
Float:
1,014,454,834
Short Interest as a % of Float:
1.6%
Average Daily Volume:
8,303,100
Outstanding Shares:
1,012,138,434
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. It operates in one business segment - human therapeutics. The company markets human therapeutic products mainly in the areas of ... (more)
| 2008 Revenue: | $15.0 B | Headquarters: Thousand Oaks, CA |
| Employees: | 17,400 | CEO: Kevin W. Sharer |
| Net Income: | $4.2 B | Industry: Biotechnology |
| Market Cap: | $57.5 B | Website: www.amgen.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| AMGN | 55.92 | -0.56 / -0.99% | 56.48 | 56.21 | 55.72 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
